ISRG · Full Picture

INTUITIVE SURGICAL INC — the full picture

Earnings window · 2026-06-30 to 2026-09-24 · anchored on the 10-Q report

One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.

What to look at first

  1. Geographic Revenue Performance · Revenue growth & mixPriority 85
    +28.4% revenue (realized); 3 sources (news, press_release, sec_filing); structured_verified
    Total revenue was $5,663.1 million for the six months ended June 30, 2026, a 21% increase versus $4,693.4 million for the six months ended June 30, 2025.
  2. Operating Income and Margins · Operating income & profitabilityPriority 73
    +17.3% operating_income (realized); 3 sources (news, press_release, sec_filing); structured_verified
    Second quarter 2026 GAAP income from operations increased to $972 million, compared with $743 million in the second quarter of 2025.
  3. Gross Margin Drivers · Gross marginPriority 67
    +11.8% operating_income (realized); 3 sources (news, press_release, sec_filing); 1 forward row(s); quote_verified
    Product gross profit was $1,642.9 million for Q2 2026, up 21% from $1,362.6 million in Q2 2025; product gross profit margin was 67.9% for Q2 2026 versus 66.5% for Q2 2025.
  4. Product Launch and Transition · Products & launchesPriority 66
    3 sources (news, press_release, sec_filing); 4 forward row(s); quote_verified
    Intuitive Surgical said the new da Vinci 5 platform (dV5) is in an early/supercycle stage and is expected to drive long-term growth.
  5. Strategic Initiatives · Strategic & business-model shiftsPriority 64
    2 sources (news, sec_filing); quote_verified
    Intuitive Surgical is pursuing expansion into new disease areas including GI, cardiac, and lung interventions.
  6. Procedure Volume Trends · Demand, orders & backlogPriority 63
    +2.2% revenue; 3 sources (news, press_release, sec_filing); 2 forward row(s); quote_verified
    One analyst projection cited expected EPS growth of 13.24% and revenue growth of 15% from the prior-year quarter for Intuitive Surgical's upcoming Q2.
  7. Capital Allocation · UnclassifiedPriority 59
    2 sources (news, sec_filing); 1 forward row(s); quote_verified
    Intuitive filed a $1.77 billion ESOP shelf registration to provide flexibility for future share issuance to employees.
  8. Regulatory Approval Milestones · Regulatory action & investigationsPriority 50
    2 sources (news, sec_filing); 2 forward row(s); quote_verified
    The da Vinci 5 cardiac clearance presents a potential ninefold expansion in cardiac procedure volumes for Intuitive Surgical.
  9. Trade Policy and Tariffs · Tariffs & trade policyPriority 50
    +1.2% operating_income (realized); 3 sources (news, press_release, sec_filing); 2 forward row(s); structured_verified
    Revenue denominated in foreign currencies was approximately 27% and 28% of total revenue for the three and six months ended June 30, 2026, respectively.
  10. Income Tax Rate Changes · TaxPriority 47
    2 sources (press_release, sec_filing); quote_verified
    Income tax expense was $231.4 million for Q2 2026 and $345.8 million for the six months ended June 30, 2026; effective income tax rate was 21.9% for Q2 2026 and 17.3% for the six months ended June 30, 2026.
  11. Recurring Revenue Mix · UnclassifiedPriority 46
    quote_verified
    In Q2 2025 Intuitive Surgical saw an 18% increase in instruments and accessories revenue.
  12. Capital Return Program · Buybacks & dividendsPriority 44
    quote_verified
    The Company repurchased 0.9 million shares of its common stock for $0.38 billion in the second quarter of 2026.

Threads by pillar

Revenue & Demand Priority 92 · 8 threads

Costs & Margins Priority 86 · 7 threads

Capital & Balance Sheet Priority 64 · 5 threads

Strategy & Portfolio Priority 68 · 5 threads

Legal, Regulatory & Policy Priority 65 · 4 threads

Guidance & Outlook Priority 44 · 1 thread

Macro & Market Conditions Priority 48 · 4 threads

Management & Governance Priority 27 · 1 thread

Unclassified Priority 70 · 5 threads

Expected impact by metric

metricforward netforward grossrealized
revenue+2.3%+2.3%+28.4%
margin-0.5%+0.5%+3.3%
cash——-1.9%
net_income——+12.4%
operating_income——+27.7%